期刊文献+

人重组TRAIL对胆囊癌细胞生长的影响 被引量:1

Effect of recombinant human TRAIL (rhTRAIL) on the growth of human gallbladder cancer cell line
下载PDF
导出
摘要 目的探讨人重组肿瘤坏死因子相关的凋亡诱导配体(recombinant human tumor necrosis factor relat-ed apoptosis inducing ligand,rhTRAIL)对胆囊癌细胞株SGC-996的作用。方法用Western-blot法检测胆囊癌细胞株中TRAIL死亡受体DR4、DR5和Fas相关死亡结构域(fas-associated death domain,FADD)的表达状况,生长曲线、相差显微镜和流式细胞仪观测rhTRAIL作用于胆囊癌细胞株后的细胞生长状况。结果胆囊癌细胞株SGC-996中,有死亡受体DR4、DR5和Fas相关死亡结构域(FADD)的表达,rhTRAIL作用胆囊癌细胞后,细胞生长受到抑制,作用前后细胞Casepase-3/7活性明显升高,流式细胞仪检测表明rhTRAIL治疗组和对照组细胞的凋亡差异明显(P<0.05)。结论rhTRAIL在体外对胆囊癌细胞株SGC-996有明显抑制作用,可能成为治疗胆囊癌的新途径。 Objective To explore the effect of recombinant human tumor necrosis factor related apoptosis inducing ligand(rhTRAIL)on gallbladder cancer cell line SGC-996.Methods TRAIL death receptor DR4,DR5,FADD were detected by Western-blot analysis.After being treated by rhTRAIL,cell viability and apoptosis of gallbladder cancer cell line SGC-996 were assayed by growth curve,phase-microscopy and flow cytometer.Results TRAIL death receptor DR4,DR5 and FADD in gallbladder cancer cell line SGC-996 were detected.After being treated by rhTRAIL,cell growth was inhibited.The proportion of apoptosis in samples treated by rhTRAIL for 24 hours was markedly increased compared with untreated samples(P〈0.05).Conclusions rhTRAIL can inhibit gowth and induce apoptosis of gallbladder cancer cell line SGC-996 in vitro,which might be a new way to treat gallbladder cancer.
出处 《复旦学报(医学版)》 CAS CSCD 北大核心 2008年第2期240-243,共4页 Fudan University Journal of Medical Sciences
关键词 肿瘤坏死因子相关凋亡诱导配体 死亡受体 胆囊癌 细胞凋亡 tumor necrosis factor related apoptosis inducing ligand death receptor gallbladder cancer apoptosis
  • 相关文献

参考文献6

  • 1Wiley SR, Schooley K, Smolak PJ, et al. Identification and characterization of a new member of the TNF family that induces apoptosis[J]. Immunity, 1995,3 (6) :673 - 682. 被引量:1
  • 2Kelley, SK. Harris LA,Xie D,et al. Preelinieal studies to predict the disposition of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand in humans: characterization of in vivo efficacy, pharmacokinetics, and safety[J]. J Pharmacol Exp Ther, 2001,299(1), 31 - 38. 被引量:1
  • 3杨耀琴,陶惠红,杨虎川.人原发性胆囊癌细胞系SGC-996的建立[J].同济大学学报(医学版),2003,24(6):457-459. 被引量:8
  • 4彭淑牖,钱浩然.努力提高我国胆囊癌外科治疗水平[J].实用肿瘤杂志,2005,20(1):5-6. 被引量:17
  • 5Marion MacFarlane . TRAIL-induced signalling and apoptosis [J]. Toxicol Letters ,2003,139(2-3) : 89 - 97. 被引量:1
  • 6Zhang XP, Jin TG, Yang HM, et al, Persistent e-FLIP(L) expression is necessary and sufficient to maintain resistance to tumor necrosis factor-related apoptosis-indueing ligand-mediated apoptosis in rrostate cancer [J], Cancer Research, 2004,, (64),7086-7091. 被引量:1

二级参考文献3

  • 1Misra S,Chaturvedi A,Misra NC, et al. Carcinoma of the gallbladder[J]. Lancet Oncol,2003,4(7) :393 - 394. 被引量:1
  • 2Horiuchi H, Kawamata H, Fujimori T, et al. A MEK inhibitor (U0126) prolongs survival in nude mice bearing human gallbladder cancer cells with K-ms mutation :analysis in a novel orthotopic inoculation model[J]. Int J Oncol,2003,23(4) :957 - 963. 被引量:1
  • 3刘博,王占民,吴小鹏,刘春生,李兆亭,刘军.胆囊癌细胞系GBC-SD的生物学行为研究[J].外科理论与实践,2001,6(3):146-148. 被引量:7

共引文献22

同被引文献19

  • 1Ashkenazi A, Pai RC, Fong S, et al. Safety and antitumor activity of recombinant soluble Apo2 ligand[J]. J Clin Invest, 1999,104:155-162. 被引量:1
  • 2Almasan A, Ashkenazi A. Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy[J]. Cytokine Growth Factor Rev, 2003,14:337-348. 被引量:1
  • 3Wang S. The promise of cancer therapeutics targeting the TNF related apoptosis-inducing ligand and TRAIL receptor pathway[J]. Oneogene, 2008,27 : 6207-6215. 被引量:1
  • 4Hu JK, Yang K, Li CM, et al. The expression of TRAIL and its receptors in gastric cancer and the apoptotic effect of rh-TRAIl. on SGC7901 cells[J]. Oncol Rep, 2009,21 : 681-688. 被引量:1
  • 5Arai T,Akiyama Y,Okabe S, et al. Genomic organization and mutation analyses of the DRS/TRAIL receptor 2 gene in colorectal carcinomas[J]. Cancer Lett, 1998,133 : 197-204. 被引量:1
  • 6Jeng YM, Hsu HC. Mutation of the DRS/TRAIL receptor 2 gene is infrequent in hepatocellular carcinoma [J]. Cancer Lett, 2002,181 ;205-208. 被引量:1
  • 7Roth W, Reed JC. FLIP protein and TRAIL-induced apoptosis [J]. Vitam Horm, 2004,67: 189-206. 被引量:1
  • 8Bin L, Li X, Xu LG, et al. The short splice form of Casper/c- FLIP is a major cellular inhibitor of TRAIL-induced apoptosis[J]. FEBS Lett, 2002,510 : 37-40. 被引量:1
  • 9Dolcet X, Llobet D, Pallares J, et al. FLIP is frequently ex- pressed in endometrial carcinoma and has a role in resistance to TRAIL-induced apoptosis[J]. Lab Invest, 2005,85:885-894. 被引量:1
  • 10Liu X, Yue P, Schonthal AH, et al. Cellular FLICE inhibitory protein down-regulation contributes to celecoxib-induced apoptosis in human lung cancer cells[J]. Cancer Res, 2006,66: 11115-11119. 被引量:1

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部